ICU Medical, Inc.
Market Cap
$3.22B
P/E Ratio
4351.67
EPS
$0.03
Dividend Yield
0.00%
52-Week Range
$107.00 — $160.29
Volume
371.49K
Avg Volume
264.14K
Beta
0.81
P/E (TTM)
4351.67
Forward P/E
16.12
PEG Ratio
41.95
P/S (TTM)
1.47
P/B (TTM)
1.54
P/FCF
107.18
EV/EBITDA
60.49x
EV/Sales
—
ROE (TTM)
0.00%
ROA (TTM)
0.00%
ROIC
0.00%
Gross Margin
0.37%
Operating Margin
0.03%
Net Margin
-0.01%
Debt/Equity
0.66
Current Ratio
2.36
EPS Growth (YoY)
+0.90%
Revenue Growth (YoY)
-0.10%
EPS Growth (3Y)
-1.32%
EPS Growth (5Y)
-0.79%
Sales Growth (3Y)
+0.26%
Sales Growth (5Y)
+0.16%
EPS Est (This Year)
$8.10
EPS Est (Next Year)
$9.27
Dividend Yield
—
Annual Dividend
—
Payout Ratio
0.00%
Frequency
—
Ex-Dividend Date
—
Cash/Share
$12.47
Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $179.00(37.1% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
24.69M
Float
23.88M
Free Float %
96.71%
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
US
Exchange
NASDAQ
IPO Date
1992-03-31
Employees
15000
CEO
Vivek Jain
Index Membership
—
Website
https://www.icumed.com
ICU Medical, Inc. (ICUI) is a healthcare company in the medical - instruments & supplies industry listed on the NASDAQ. With a market capitalization of $3.22B, a P/E ratio of 4351.67, ICUI is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ICUI against other stocks using dozens of fundamental and technical filters.
ICU Medical, Inc. (ICUI) has a trailing twelve-month (TTM) P/E ratio of 4351.67. This is above the market average, which may reflect high growth expectations or premium valuation. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, ICU Medical, Inc. (ICUI) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
ICU Medical, Inc. (ICUI) has a market capitalization of $3.22 billion, classifying it as a mid-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Buy" rating on ICU Medical, Inc. (ICUI) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $179.00 implies 37.1% upside from the current price.